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Abstract. 
 
All known proteins that accumulate in the 
vacuolar space surrounding the obligate intracellular 
protozoan parasite 
 
Toxoplasma gondii
 
 are derived 
from parasite dense granules. To determine if constitu-
tive secretory vesicles could also mediate delivery to 
the vacuolar space, 
 
T. gondii
 
 was stably transfected 
with soluble 
 
Escherichia coli
 
 alkaline phosphatase and 
 
E. coli
 
 
 
b
 
-lactamase. Surprisingly, both foreign secretory 
reporters were delivered quantitatively into parasite 
dense granules and efficiently secreted into the vacu-
olar space. Addition of a glycosylphosphatidylinositol 
membrane anchor rerouted alkaline phosphatase to 
the parasite surface. Alkaline phosphatase fused to the 
transmembrane domain and cytoplasmic tail from the 
endogenous dense granule protein GRA4 localized to 
dense granules. The protein was secreted into a tubore-
ticular network in the vacuolar space, in a fashion de-
pendent upon the cytoplasmic tail, but not upon a ty-
rosine-based motif within the tail. Alkaline 
phosphatase fused to the vesicular stomatitis virus G 
protein transmembrane domain and cytoplasmic tail lo-
calized primarily to the Golgi, although staining of 
dense granules and the intravacuolar network was also 
detected; truncating the cytoplasmic tail decreased 
Golgi staining and increased delivery to dense granules 
but blocked delivery to the intravacuolar network. Tar-
geting of secreted proteins to 
 
T. gondii
 
 dense granules 
and the plasma membrane uses general mechanisms 
identified in higher eukaryotic cells but is simplified 
and exaggerated in scope, while targeting of secreted 
proteins beyond the boundaries of the parasite involves 
unusual sorting events.
 
T
 
oxoplasma
 
 gondii
 
 is an obligate intracellular pro-
tozoan parasite that is the leading cause of focal
central nervous system infections in HIV-infected
patients. This parasite is capable of invading and replicat-
ing within all nucleated mammalian cells. 
 
T. gondii 
 
resides
intracellularly within a vacuole that neither acidifies nor
fuses with organelles of the endocytic cascade (for review
see Sinai and Joiner, 1997). The intracellular parasite se-
cretes prodigious amounts of proteins into the vacuolar
space enclosed by the parasitophorous vacuolar mem-
brane (PVM),
 
1 
 
which surrounds the parasite inside cells
(for review see Silverman and Joiner, 1996). These se-
creted proteins associate with the PVM, with a tubulore-
ticular network in the vacuolar space (Sibley et al., 1986),
or with both.
 
T. gondii
 
 and related Apicomplexan parasites (e.g.,
Plasmodia, Cryptosporidia, Sarcocystis, Eimeria) contain
three morphologically distinct secretory organelles (rhop-
tries, micronemes, and dense granules), providing a partic-
ularly interesting model for studying secretory granule tar-
geting. Dense granules are 200-nm organelles localized
throughout the parasite (for review see Cesbron-Delauw,
1994). In contrast to the anterior rhoptries and micro-
nemes, organelles that discharge at the time of invasion
(Perkins, 1992), dense granule exocytosis is thought to oc-
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1. 
 
Abbreviations used in this paper
 
: BAP, bacterial alkaline phosphatase;
BFA, brefeldin A; BLA, bacterial 
 
b
 
-lactamase; CRD, cross-reacting de-
 
terminant; CSV, constitutive secretory vesicles; DHFR, dihydrofolate re-
ductase; GPI, glycosylphosphatidylinositol; ISG, immature secretory
granules; MSG, mature secretory granules; NTPase, nucleoside triphos-
phate hydrolase; PI-PLC, phosphatidylinositol-specific phospholipase C;
PVM, parasitophorous vacuolar membrane; UTR, untranslated region;
VSV-G, vesicular stomatitis virus.
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cur primarily after invasion, and to continue during the in-
tracellular residence of the organism (Dubremetz et al.,
1993; Carruthers and Sibley, 1997).
10 dense granule proteins are identified in 
 
T. gondii
 
:
GRA1–GRA7, two isoforms of the nucleoside triphos-
phate hydrolase (NTPase), and cyclophilin 18 (for reviews
see Cesbron-Delauw, 1994; Silverman and Joiner, 1996).
Except for cyclophilin 18, these proteins not only lack sig-
nificant homology with other proteins in the data base, but
they also bear limited amino acid sequence homology with
one another. No common sequences are identified that
might target these proteins to dense granules. GRA4,
GRA5, GRA6, and GRA7 contain putative transmem-
brane domains, yet all are secreted into the vacuolar space
and localize to the vacuolar network (GRA4 and GRA6),
to the PVM (GRA5), or to both (GRA7). In contrast, the
Figure 1. BAP and BLA are stably expressed in
T. gondii tachyzoites and localize to parasite
dense granules. (A) Organization of the NTPase
59 UTR containing the promoter (Nakaar et al.,
1997), NH2-terminal signal sequence (SS), and 39
UTR in the plasmid pNTPSec. AvrII and BglII
restriction sites were used for inserting the cod-
ing regions of E. coli alkaline phosphatase (phoA)
and  b-lactamase (bla). (B) Expression of the
transgenes in single clones from BAP (a–d) or
BLA (e–h) transfected parasites was monitored
by SDS-PAGE and immunoblot. Also shown are
nontransfected parasites (RH) and uninfected
Vero cells, indicating no cross-reaction of the an-
tibody with endogenous parasite or cell proteins.
(C) Phase contrast and corresponding immuno-
fluorescence images of single clones stained with
antibody to the endogenous dense granule pro-
tein GRA3 or with antibodies to BAP or to
BLA. Precise colocalization of GRA3 with BAP
or GRA2 with BLA in dense granules is shown
(arrows). (D and E) Ultrathin cryosections of in-
tracellular  T. gondii stably expressing BAP or
BLA viewed by immunoelectron microscopy.
Gold particles were localized in dense granules
(DG) (D, BAP; E, BLA) and the intravacuolar
network (NW) for BAP (D). Bars, 100 nm. 
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five major surface proteins of 
 
T. gondii
 
, including SAG1,
are anchored to the plasma membrane by glycosylphos-
phatidylinositol (GPI) membrane anchors (Nagel and
Boothroyd, 1989; Tomavo et al., 1989) and are not found
in the vacuolar space. The vesicles transporting GPI-anchored
proteins to the parasite plasma membrane are not identi-
fied.
While there is little precedent for understanding protein
sorting events to secretory organelles and to the vacuolar
space in 
 
T. gondii
 
 or in any other pathogenic protozoan
parasite (Becker and Melkonian, 1996), all secreted pro-
teins in higher eukaryotic cells, whether soluble or mem-
brane associated, follow an identical pathway from the en-
doplasmic reticulum to the TGN (Burgess and Kelly,
1987). In secretory cells, immature secretory granules
(ISG) form in the 
 
trans
 
-Golgi and are sorted at that point
from constitutive secretory vesicles (CSV) (for review see
Urbe et al., 1997). Soluble and membrane granule proteins
accumulate in ISG, either by signals mediating entry or by
signals mediating retention. Motifs within the ectodomain
or cytoplasmic tail of transmembrane proteins may confer
information for targeting to or removal from ISG during
their formation and subsequent maturation to mature
secretory granules (MSG) (Didier et al., 1992; Colomer
et al., 1994; Milgram et al., 1996; Dittie et al., 1997; for re-
view see Urbe et al., 1997). GPI-anchored proteins may
also be components of secretory granules through signals
contained in the ectodomain (Colomer et al., 1996).
To explore the population of vesicles that transport sol-
uble proteins in 
 
T. gondii
 
, the parasite was stably trans-
formed with the genes for two soluble foreign secretory re-
porters, 
 
E. coli
 
 
 
b
 
-lactamase (BLA) and 
 
E. coli
 
 alkaline
phosphatase (BAP), which should not contain targeting
information for delivery to secretory granules. Surpris-
ingly, both reporters localized quantitatively to parasite
dense granules, allowing subsequent analysis of targeting
signals conferred by addition of membrane anchoring do-
mains to BAP. 
 
Materials and Methods
 
Buffers
 
Buffers, including PBS, artificial intracellular salt solution (AISS), elec-
troporation buffer, lysis buffer, and immunoprecipitation wash buffer,
were as reported earlier (Ossorio et al., 1994; Roos et al., 1994; Beckers
et al., 1995). For secretion assays, AISS buffer with 1
 
3
 
 vitamin/amino acid
mix (RPMI-1640 Select Amine Kit; GIBCO BRL, Gaithersburg, MD), 5 mM
ATP, and protease inhibitors (1 mM PMSF, 5 
 
m
 
M leupeptin, 1 
 
m
 
M aproti-
nin, 5 
 
m
 
M pepstatin, and 100 
 
m
 
g/ml chymostatin) was used. Biotinylation
buffer consisted of 10 mM triethanolamine, pH 9.0, 2 mM CaCl
 
2
 
, 150 mM
NaCl.
 
Reagents
 
Restriction endonucleases, T4 polymerase, and DNA ligase were from
New England Biolabs (Beverly, MA). Taq polymerase was from Perkin-
Elmer Cetus (Norwalk, CT). DNA sequenase version 2.0 dideoxy chain
termination kit was from U.S. Biochemical (Cleveland, OH). Geneclean
II was from Bio 101 (La Jolla, CA). Rabbit antibacterial alkaline phos-
phatase (BAP) and anti-BLA were from 5 Prime 
 
®
 
 3 Prime (Boulder, CO).
Methionine-free DME and was from GIBCO BRL. Pro-mix 
 
l
 
-
 
35
 
S in vivo
cell labeling mix and ECL detection kit were from Amersham Corp. (Ar-
lington Heights, IL). Protein A–Sepharose CL-4B was from Pharmacia Bio-
tech (Piscataway, NJ). Phospholipase C was stored at 
 
2
 
20
 
8
 
C in 10 mM Tris,
pH 7.5 with 50% glycerol (ICN Pharmaceuticals, Aurora, OH). NHS-SS-biotin,
stored at 200 mg/ml in DMSO, and streptavidin beads were from Pierce
Chemical Co. (Rockford, IL). All other chemicals were from Sigma
Chemical Co. (St. Louis, MO).
 
Growth of Parasites in Mice and Tissue Culture Cells
 
T. gondii 
 
RH strain tachyzoites lacking hypoxanthine-guanine-xanthine
phosphoribosyl transferase (provided by D. Roos, University of Pennsyl-
vania, Philadelphia, PA) were maintained by serial passage in the perito-
neum of Swiss-Webster mice or by in vitro culture in Vero cells or human
foreskin fibroblasts as previously described (Beckers et al., 1994). Para-
sites stably expressing BAP or BLA were maintained by serial passage in
host cells at 37
 
8
 
C in medium containing 25 
 
m
 
g/ml mycophenolic acid and
50 
 
m
 
g/ml xanthine. RH strain tachyzoites expressing BAP-GPI, BAP-
GRA4 constructs, and BAP-G constructs together with the dihydrofolate
reductase (DHFR) gene were maintained in medium containing 1 
 
m
 
M py-
rimethamine.
 
Plasmid Constructs
 
All secretion reporters were initially cloned into the plasmid pNTP/sec
(Karsten et al., 1997) for transient expression. This vector contained the 5
 
9
 
untranslated region (UTR) and 3
 
9 
 
UTR and NH
 
2
 
-terminal signal se-
quence from the gene for the 
 
T. gondii 
 
NTPase, an endogenous dense
granule protein, as well as an AvrII/BglII cloning site (Fig. 1 
 
A
 
).
For the BAP construct, an AvrII/BglII fragment coding for residues
23–449 of the BAP sequence was amplified from plasmid pHI (Inouye
et al., 1981). For the BLA gene, an AvrII/BglII fragment coding for BLA
Figure 2. Short-term BFA treatment does not block BLA secre-
tion but inhibits SAG1 delivery to the plasma membrane. (A)
BLA release from extracellular parasites is not blocked by short-
term treatment with BFA. Infected monolayers containing BLA-
expressing parasites were incubated for 60 min at 37°C with or
without BFA, at which point parasites were liberated from the
host cells. BLA secreted from the extracellular parasites during
continued incubation at 37°C was quantitated by enzymatic as-
say. There was no difference in the amount of protein released by
BFA-treated or untreated parasites. The release over 1 h corre-
sponds to 22–23% of total parasite BLA at time 0. Similar results
were observed for release of BAP and the endogenous dense
granule protein GRA3 (not shown). (B) Delivery of SAG1 to the
parasite surface is inhibited by short-term treatment with BFA.
Infected monolayers were treated with or without BFA for 1 h to
deplete Golgi-derived constitutive secretory vesicles and then
metabolically labeled for an additional hour in the continued
presence or absence of BFA. Parasites liberated from the in-
fected cells were surface biotinylated. After surface biotinylation,
lysed parasites were immunoprecipitated with SAG1 and protein
A beads to quantitate the total (Total lanes) amount of labeled
SAG1 present. In half of the sample, biotinylated SAG1 was de-
termined by releasing bound SAG1 from protein A beads and re-
binding to Avidin Sepharose beads (Surface lanes). In untreated
parasites, 46% of total SAG1 was detected on the parasite sur-
face after 1 h of continuous labeling, whereas less than 7% of to-
tal SAG1 was on the surface in BFA-treated parasites. 
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was amplified from pBluescript. For the BAP-GPI construct, a PstI/BglII
fragment of SAG1 coding for residues 287–319 was amplified from 
 
T. gon-
dii 
 
genomic DNA (Burg et al., 1988). The digested and purified PCR
product together with an AvrII/PstI fragment of BAP were cloned into
pNTP/sec cut with AvrII and BglII. BAP-GRA4 was of similar design and
contained residues 275–345, encoding the putative transmembrane do-
main and cytoplasmic tail, fused downstream of BAP. The GRA4 frag-
ment was amplified from genomic DNA (Mevelec et al., 1992). The BAP-
GRA4
 
tail
 
2
 
 construct was made by introducing a stop codon at residue 298
of the GRA4 domain. BAP-GRA4
 
Y332A 
 
was prepared by mutating codon
332 from tyrosine to alanine. BAP-G contained residues 464–511 from the
vesicular stomatitis virus G (VSV-G) protein, encoding the transmem-
brane domain and cytoplasmic tail, introduced downstream of BAP. The
VSV-G fragment was amplified from pSVGL1 (Rose and Bergmann,
1983) and cloned with an AvrII/PstI fragment of BAP into pNTP/Sec. To
make BAP-G
 
tail
 
2
 
, a stop codon was introduced at codon 489 of the VSV-G
tail to yield a protein with five cytoplasmic residues. BAP-G
 
Y501A
 
 was con-
structed by mutating codon 501 (coding for tyrosine) of the VSV-G tail to
code for alanine (Thomas et al., 1993).
Plasmids for stable transfection were prepared by digesting the above
constructs with SpeI. The SpeI fragments were subcloned into the SpeI
site of pminCAT/HXGPRT or pDHFR-TSc3 containing the mutated
DHFR gene conferring pyrimethamine resistance (kindly provided by D.
Roos) (Donald et al., 1996), as described earlier (Karsten et al., 1997).
 
Primers
 
All primers are 5
 
9
 
 to 3
 
9
 
. BAP-AvrII/BglII: CGC CTA GGG ACA CCA
GAA ATG CCT GTT C and CGG AGA TCT TTA TTT TCA GCC
CCA GGG. BLA: GAA GCC TAG GCC ACC CAG AAA CGC TGG
TG and GGA AGA TCT TAC CAA TGC TTA ATG AG. BAP-AvrII/
PstI: CGC CTA GGG ACA CCA GAA ATG CCT GTT C and GGC
TGC AGC TTT CAG CCC CAG GGC GGC. SAG1: GGG GCT GCA
GGG TCA GCA and GGA GAT CTC ACG CGA CAC AAG CTG CG.
GRA4: GGT CGC TGC AGG AAT CCT GAC GGG and CAG AGA
TCT CAC TCT TTG CGC TTG CGC ATT C. BAP-GRA4
 
tail
 
2
 
: GCC
AAG ATC TCA CTT GAC AGC CTT TGC. BAP-GRA4
 
Y332A
 
: GAG
AGA TCT CAC TCT TTG CGC ATT CTT TCC AAA TCC TTC AAT
AAC TCG GCG GGT GAG GGT CGC GGG. VSV-G: TTC ACT GCA
GGC AAA AGC TCT ATT GCC and GCA GAT CTT ACT TTC CAA
GTC GGT TC. BAP-G
 
tail
 
2
 
: CGA AAT TAA ATT CTA GAG TTA
CCT ATG G. BAP-G
 
Y501A
 
: GCA GAT CTT ACT TTC CAA GTC GGT
TCA TCT CTA TGT CTG TAG CAA TCT GTC TTT T.
Figure 3. GPI-anchored alkaline phosphatase lo-
calizes to the plasma membrane by immunofluo-
rescence and immunoelectron microscopy. (A)
Design of BAP-GPI construct showing the addi-
tion of the SAG1-GPI anchor addition site to
BAP. (B) Infected cells containing parasites
transfected with BAP-GPI were fixed and per-
meabilized with either methanol (MeOH), which
optimizes detection of proteins on the parasite
surface or secreted into the vacuolar space, or
with paraformaldehyde and Triton X-100 (PFA/
Tx), which optimizes staining of dense granules
and other organelles within the parasite. Fixed
samples were stained with the anti-GRA3 mAb
and the anti-BAP antiserum. Note the presence
for BAP-GPI of surface staining (MeOH, anti-
BAP), but the absence of dense granule staining
(PFA/Tx, anti-BAP), when compared with stain-
ing for GRA3. (C and D) Cryosections of BAP-
GPI–expressing parasites were labeled with anti-
bodies to SAG1 (5-nm gold) and antibodies to
BAP (10-nm gold). 5- and 10-nm gold particles
colocalize at the plasma membrane (PM) and in-
ner membrane complex (IMC) of transgenic par-
asites. In perinuclear areas, membranes of large
electron-lucent vesicles (V) were labeled with
gold particles of both sizes (C). Bars, 200 nm. 
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Transfection and Selection of Stable Lines
 
Transient transfection was performed as described (Roos et al., 1994).
Plasmid DNA for transfection was isolated using Qiagen plasmid kits
(Chatsworth, CA). For preparation of stable lines, electroporated para-
sites were cultured in Vero or HFF cells in selection media and then
cloned by growth under soft agar as described earlier (Karsten et al.,
1997). A 10-cm Petri dish containing Vero cells was infected with about
200 parasites and incubated at 37
 
8
 
C for 20 h. The monolayer was washed
three times with PBS
 
11
 
 
 
(plus Mg
 
2
 
1
 
 and Ca
 
2
 
1
 
) and replaced with a mixture
of 2
 
3
 
 Vero medium plus either 2 
 
m
 
M pyrimethamine or 50 
 
m
 
g/ml myco-
phenolic acid and 100 
 
m
 
g/ml xanthine and warm 1.6% agarose (43
 
8
 
C).
Dishes were incubated until colonies appeared, and then clones were
picked and expanded.
Immunofluorescence and Immunoelectron Microscopy
Immunofluorescence on infected cells or extracellular parasites was done
as previously reported (Joiner et al., 1990). Detection was performed with
rabbit anti-BAP (1:500) or anti-BLA (1:100) and mouse monoclonal anti-
bodies to GRA3 (T62H11) or GRA2 (T41F51D10) diluted 1: 250 in PBS
containing 3% BSA, followed by FITC-conjugated goat anti–rabbit IgG
and rhodamine-conjugated goat anti–mouse IgG diluted 1:500 in PBS con-
taining 3% BSA. Coverslips were mounted with Mowiol and observed
with an epifluorescence microscope (model Microphot FXA; Nikon, Inc.,
Melville, NY). Images were captured with a CCD camera (Photometrics,
Tuscon, AZ) and processed with Image-Pro Plus (Media Cybernetics, Sil-
ver Spring, MD).
For immunoelectron microscopy, monolayers of Vero cells were in-
fected with transgenic T. gondii for 24 h. Infected cells were processed,
and sections for immunoelectron microscopy were prepared as previously
described (Beckers et al., 1994). Sections were labeled with rabbit anti-
BAP (1:250), rabbit anti-BLA (1:100), and mouse anti-SAG1 (T41E5) (1:
2,000) antibody in PBS containing 10% BSA.
SDS-PAGE and Immunoblot
SDS-PAGE and immunoblot were performed according to Laemmli
(1970) and Towbin (1979). Immunoblots were developed using rabbit anti-
BAP (1:5,000), rabbit anti-BLA (1:1,000), mouse anti-SAG1 (1:1,000), or
rabbit anti–cross-reacting determinant (CRD, 1:2,000) (provided by P.
Englund, Johns Hopkins University, Baltimore, MD) (Bangs et al., 1985)
followed by goat anti–rabbit IgG-HRP or goat anti–mouse IgG-HRP con-
jugate (1:2,000), and the ECL detection system (Amersham Corp.).
Quantitation of BLA Released from Extracellular 
Parasites Treated with Brefeldin A
BLA release from extracellular parasites treated with brefeldin A (BFA)
was quantitated by enzymatic assay. Six 10-cm Vero dishes with 2–3 3 107
BLA-expressing parasites, or three 10-cm uninfected Vero dishes as con-
trol, were incubated at 378C for 36–40 h. BFA (50 mg/ml) was added to
three infected dishes, and incubation was continued at 378C for 60 min. A
high concentration of a BFA was required to completely disperse the T.
gondii Golgi complex, as assessed by immunofluorescence microscopy an-
tiserum (kindly provided by G. Wood, University of Vermont, Burlington,
VT) and G. Langsley (Institut Pasteur, Paris, France) to Plasmodium fal-
ciparum Rab6. Plates were then put on ice and washed three times with
cold secretion buffer. The monolayer was scraped into cold buffer and
passed twice through a 27-gauge needle. Then parasites were harvested by
centrifugation at 1,450 g for 5 min at 48C. Parasites were washed 33 at 48C
with secretion buffer. To a total of 2 3 108 extracellular parasites in 1 ml,
BFA (20 mg/ml) was added for previously BFA-treated parasites. After
incubation at 378C for 0, 30, 60, and 120 min, 250-ml aliquots were re-
moved and spun at 7,000 rpm for 10 min at 48C, and the supernatant was
transferred to a fresh tube. BLA enzymatic activity in the supernatant was
quantitated using described procedures (Laminet and Pluckthun, 1989)
with modifications (Karsten et al., 1997).
Surface Delivery of SAG1 in the Presence and Absence 
of BFA
Delivery of SAG1 to the parasite surface, with or without BFA treatment,
was assessed by biotinylation. Infected monolayers (24 h) were suspended
in 2 ml/dish methionine and cysteine-free DME with or without 50 mg/ml
BFA. After incubation at 378C for 1 h, 125 mCi pro-mix l-35S in vivo cell
labeling mix was added to each dish. Incubation was continued at 378C for
another 60 min, and parasites were liberated as described above.
For surface biotinylation, the parasite pellet was suspended in NHS-
SS-biotin (1.5 mg/ml) in biotinylation buffer at 48C for 30 min with very
gentle agitation. Parasites were centrifuged at 1,450 g at 48C for 5 min and
then resuspended in 1 ml PBS21 with 100 mM glycine and incubated at
48C for 20 min to quench unreacted biotin.
For immunoprecipitation, parasite pellets were washed, suspended in
lysis buffer, and precleared on protein A–Sepharose. To precleared ly-
sates, 5 ml mouse anti-SAG1 (T41E5) and 100 ml protein A–Sepharose
beads were added, and incubation continued at 48C overnight. After
washing, the beads were divided into two samples. For surface SAG1
quantification, 100 ml 1% SDS in 50 mM Tris-Cl, pH 7.5, 100 mM NaCl
was added, and incubation was continued at 808C for 10 min to elute
bound SAG1. 900 ml lysis buffer was added to the beads, which were cen-
trifuged at 1,500 rpm for 5 min, and the supernatant was transferred to a
fresh tube containing 30 ml packed streptavidin beads. After overnight in-
cubation at 48C, beads were washed. Both total (protein A–Sepharose)
and surface SAG1 (streptavidin beads) were quantitated by SDS-PAGE
autoradiography and PhosphorImager analysis.
Phospholipase C Treatment
The presence of the GPI anchor was assessed by digestion with phosphati-
dylinositol-specific phospholipase C (PI-PLC). Parasites were harvested
from infected monolayers and washed 33 in cold MEM without FCS. 1.5 3
107 RH strain–, BAP-, or BAP-GPI–expressing parasites were incubated
with 0.1 U PI-PLC (ICN Biomedicals, Costa Mesa, CA) in MEM or in
MEM without the enzyme for 1 h at 378C. The reaction volume was 30 ml.
Treated parasites were recovered by centrifugation (5 min, 1,450 g, 48C),
and the supernatants were saved. The cells were washed three times in
MEM and then lysed in 30 ml SDS loading buffer. All samples were ana-
lyzed by SDS-PAGE and immunoblot.
Figure 4. Phospholipase C treatment exposes a CRD epitope in
BAP-GPI. RH strain, BAP-expressing, or BAP-GPI–expressing
parasites were treated with PI-PLC (1) or incubated in medium
(2). After treatment, the parasites were centrifuged, and the re-
sulting supernatants (S) and pellets (P) were analyzed by SDS-
PAGE and immunoblot with antibodies to the CRD (Bangs et
al., 1985), an epitope of the GPI anchor that is exposed only after
cleavage with PLC. The CRD epitope was exposed on endoge-
nous parasite proteins released into the supernatant, regardless
of whether wild-type RH strain parasites or transgenic parasites
expressing BAP or BAP-GPI parasites were tested (lanes 4, 8,
and 12). These bands correspond to the endogenous surface pro-
teins SAG1 (30 kD), SAG2 (22 kD), SAG3 (43 kD), p23, and
p35. A small amount of SAG1 expressing the CRD epitope was
present on the parasite surface after PI-PLC treatment (lanes 2,
6, and 10). In contrast, only BAP-GPI–expressing parasites
treated with PI-PLC released BAP into the supernatant (lane 12).The Journal of Cell Biology, Volume 141, 1998 1328
Figure 5. BAP-GRA4 localizes to dense gran-
ules and requires the cytoplasmic tail for efficient
secretion into the intravacuolar network. (A)
Design of BAP-GRA4, BAP-GRA4tail2, and
BAP-GRA4Y332A constructs, showing addition of
the GRA4 transmembrane and cytoplasmic tail
to BAP and the two alterations within the tail.
All of the constructs behaved as integral mem-
brane proteins when analyzed in a heterologous
in vitro translation/translocation system (not
shown). (B) Infected cells containing parasites
expressing BAP-GRA4, BAP-GRA4tail2, or
BAP-GRA4Y332A were fixed with PFA and per-
meabilized with Triton X-100 to optimize stain-
ing of dense granules and other internal or-
ganelles of the parasite. Cells were stained with
antibodies to BAP or the dense granule marker
GRA3. The BAP signal colocalized with staining
for GRA3 in all three chimeras, demonstrating
delivery of BAP-GRA4, BAP-GRA4tail2, and
BAP-GRA4Y332A to dense granules (arrows).
(C) Infected cells containing parasites expressing
BAP-GRA4, BAP-GRA4tail2, or BAP-GRA4Y332A
were fixed with MeOH to optimize detection of
proteins secreted into the vacuolar space. Cells
were stained with antibodies to BAP or GRA3.
The arrowheads show network staining for the
BAP-GRA4 and BAP-GRA4Y332A constructs.
Only minimal amounts (arrowhead) of GRA4tail2
were detected in the vacuolar space. (D) Cryo-
sections of BAP-GRA4–expressing parasites
stained with antibodies to BAP. Gold particles
localize primarily to dense granules (DG) and the
intravacuolar network (NW), with some staining
of the plasma membrane (PM). Bar, 200 nm.Karsten et al. Protein Targeting in Toxoplasma gondii 1329
Subcellular Fractionation of Infected Cells
Vero cell monolayers were infected with parasites expressing BAP, BAP-
GPI, or BAP-G for 20–40 h. Plates were put on ice and then washed three
times with PBS with protease inhibitors. The monolayer was scraped into
buffer and passed twice through a 27-gauge needle. The parasites were
harvested by centrifugation at 1,450 g for 5 min at 48C. The supernatant
was centrifuged at 10,000 g for 10 min at 48C to pellet (10K pellet) the
bulk of the intravacuolar network and any partially disrupted parasites
(Ossorio et al., 1994). The supernatant was centrifuged at 100,000 g for 60
min at 48C to pellet the remaining network (100K pellet). Proteins within the
100,000 g supernatant (100K supernatant) were precipitated with trichlo-
roacetic acid. All fractions were analyzed by SDS-PAGE and immunoblot.
Results
E. coli Alkaline Phosphatase and b-Lactamase Are 
Stably Expressed in T. gondii Tachyzoites
Both soluble BAP and BLA were stably expressed in T.
gondii. As shown in Fig. 1 B, BAP and BLA were readily
detected by immunoblot in extracellular tachyzoites. Both
reporters were of the expected size after signal sequence
cleavage and comigrated with the endogenous protein ex-
pressed in E. coli (not shown), indicating that neither pro-
teolysis, inappropriate processing, nor significant post-
translational modifications occurred in T. gondii.
BAP and BLA Localize to Dense Granules by 
Immunofluorescence and Immunoelectron Microscopy
Within intracellular parasites, both BAP and BLA local-
ized by immunofluorescence to discrete punctate struc-
tures consistent with dense granules (Fig. 1 C). Dense
granule localization was confirmed by colocalization of the
BAP and BLA signals with the endogenous dense granule
proteins GRA2 and GRA3.
Localization of BAP and BLA to dense granules was
confirmed by immunoelectron microscopy (Fig. 1, D and
E). Both BAP (Fig. 1 D) and BLA (not shown) also asso-
ciated with the intravacuolar network within the parasito-
phorous vacuole space, suggesting that localization of sol-
uble proteins to the network morphologically does not
depend upon parasite-specific sequences.
Release of BLA from T. gondii Dense Granules Is Not 
Blocked by Brefeldin A
These results suggest that the pathway for soluble secre-
tory proteins in T. gondii is to dense granules. They do
not, however, preclude the simultaneous delivery of solu-
ble secretory proteins into more typical CSV, which also
carry soluble cargo to and fuse with the plasma membrane.
These vesicles are generally difficult to detect by electron
microscopy because of their low abundance, presence in a
background of membrane structures, and low concentra-
tion of cargo.
We distinguished between these possibilities using BFA.
Secretion from preformed dense core granules is not
blocked by BFA (Rosa et al., 1992), whereas CSV, which
move rapidly to the plasma membrane, are depleted in the
presence of the drug. There was no significant effect on
BLA secretion after 1 h of treatment with BFA (Fig. 2 A).
Under these same conditions, BFA did block vesicular
transport in the parasite, since delivery of the GPI-anchored
surface protein SAG1 to the parasite plasma membrane
was inhibited by over 85% (Fig. 2 B). Taken together,
these results suggest that soluble BAP and BLA are quan-
titatively delivered to dense granules.
Addition of a GPI Anchor to BAP Results in Expression 
on the Plasma Membrane
We therefore tested whether a GPI anchor was sufficient
to route BAP out of dense granules and into CSV. The 33
residue GPI anchor addition site from SAG1 was added to
the COOH terminus of BAP (Fig. 3 A). Alkaline phos-
phatase with a GPI anchor (BAP-GPI) was clearly ex-
pressed on the surface of T. gondii as shown by immuno-
fluorescence microscopy (Fig. 3 B). Immunoelectron
microscopy showed colocalization of BAP-GPI with the
surface antigen SAG1 (Fig. 3, C and D). No localization to
dense granules was found, whereas both BAP-GPI and
SAG1 were detected in association with the membrane at
the periphery of large electron-lucent vesicles of larger
than 500 nm in diameter (Fig. 3 D).
We confirmed that BAP-GPI was linked to the plasma
membrane of T. gondii by a GPI anchor (Fig. 4). Parasites
expressing BAP-GPI were treated with PI-PLC, and the
release of BAP containing the CRD, indicative of cleavage of
a GPI-membrane anchor, was demonstrated by immunoblot.
Taken together with the results in Figs. 2 and 3, these
data indicate that a GPI anchor is sufficient to target pro-
teins to the plasma membrane in T. gondii, and that the
predominant pathway for GPI-anchored proteins is to the
plasma membrane.
Addition to BAP of the Putative Transmembrane 
Domain and Cytoplasmic Tail from GRA4 Results in 
Delivery to Dense Granules and Secretion into the 
Vacuolar Space
We next fused BAP to the putative transmembrane do-
main and tail from GRA4 (Mevelec et al., 1992), one of
four dense granule proteins in T. gondii that contain a lin-
ear stretch of hydrophobic amino acids near the COOH
terminus (Fig. 5 A). While predicted to be a type I integral
membrane protein (and one of only a handful of such pro-
teins identified to date in the organism), endogenous
GRA4 is nonetheless secreted into the vacuolar space in
association with the intravacuolar network.The Journal of Cell Biology, Volume 141, 1998 1330
Figure 6. BAP-G localizes to the Golgi and re-
quires the cytoplasmic tail for efficient secretion
into the intravacuolar network. (A) Design of
BAP-G, BAP-Gtail2, and BAP-G Y501A constructs,
showing addition of the VSV-G transmembrane
and cytoplasmic tail to BAP and the two alter-
ations within the tail. (B) Infected cells contain-
ing parasites expressing BAP-G, BAP-Gtail2, or
BAP-GY501A were fixed with PFA, permeabi-
lized with Triton X-100, and then stained with
antibodies to GRA3 or BAP. The arrows show
staining of the parasite Golgi for the BAP-G and
BAP-GY501A constructs. Golgi localization was
not observed with BAP-Gtail2. Extensive colocal-
ization of BAP-Gtail2 and BAP-GY501A with GRA3
was noted, whereas the extent of dense granule
staining for BAP-G was variable and less in-
tense. (C) Infected cells containing parasites ex-
pressing BAP-G, BAP-Gtail2, or BAP-GY501A
were fixed with MeOH. Cells were stained with
antibodies to BAP or GRA3. Arrowheads show
network staining for BAP-G and BAP-GY501A.
Network staining for BAP-Gtail2 was minimal.
(D and E) Cryosections of BAP-G–expressing
parasites stained with antibodies to BAP. Gold
particles localize primarily to the Golgi (D), the
plasma membrane (PM), and the intravacuolar
network (NW), with occasional staining of dense
granules (E, DG). Bars, 200 nm.Karsten et al. Protein Targeting in Toxoplasma gondii 1331
BAP-GRA4 localized to dense granules (Fig. 5 B, ar-
rows; Fig. 5 D) and was secreted in large amounts into the
vacuolar space (Fig. 5 C, arrowheads) in association with
the intravacuolar network (Fig. 5 D). BAP-GRA4 was
also detected by immunoelectron microscopy at the para-
site plasma membrane (Fig. 5 D), suggesting that delivery
into the vacuolar space followed fusion of dense granules
with the plasma membrane.
Truncating the GRA4 Cytoplasmic Tail Blocks Delivery 
to the Vacuolar Space
Truncating the cytoplasmic tail of GRA4 four residues
downstream of the putative transmembrane domain to
generate BAP-GRA4tail2 did not alter localization to
dense granules (Fig. 5 B), but the chimera was not secreted
efficiently into the vacuolar space (Fig. 5 C). In contrast, a
Y332A substitution within a potential tyrosine-based sort-
ing motif (Fig. 5 A, YAEL) in the GRA4 cytoplasmic tail
had no effect on localization to dense granules (Fig. 5 B)
or secretion into the vacuolar space (Fig. 5 C).
Addition to BAP of the VSV-G Transmembrane 
Domain and Cytoplasmic Tail Results in Accumulation 
within the Golgi
To determine whether the localization observed with
BAP-GRA4 and mutants was seen with a foreign trans-
membrane domain and cytoplasmic tail, we added these
regions from VSV-G to BAP to generate BAP-G (Fig. 6
A). BAP-G localized to a crescent-shaped structure ante-
rior to the nucleus (Fig. 6 B, BAP-G, arrows), confirmed
by immunoelectron microscopy to be the parasite Golgi
(Fig. 6 D). BAP-G was detected to a lesser extent in vesic-
ular structures containing GRA3. Dense granule localiza-
tion was confirmed by immunoelectron microscopy (Fig. 6
E). BAP-G also localized to the vacuolar space, but not to
the vacuolar membrane (Fig. 6 C, BAP-G, arrowhead).
The BAP-G signal was detected by electron microscopy at
the plasma membrane and in the intravacuolar network
(Fig. 6, D and E).
Partial deletion of the VSV-G cytoplasmic tail alters lo-
calization of BAP-G. Motifs in the VSV-G tail dictate ei-
ther forward transport from the ER to Golgi (Nishimura
and Balch, 1997), or basolateral targeting in polarized epi-
thelial cells (Thomas et al., 1993). We therefore truncated
the VSV-G tail five residues downstream of the trans-
membrane domain (Fig. 6 A, BAP-Gtail2). This construct
localized to vesicular structures containing GRA3 (Fig. 6
B, BAP-Gtail2). No staining was detected in the region of
the parasite Golgi. The BAP-Gtail2 chimera was not de-
tected in the vacuolar space (Fig. 6 C, BAP-Gtail2). Substi-
tution of the single tyrosine within the VSV-G tail to alanine
(Fig. 6 A, BAP-GY501A) did not eliminate Golgi staining
but generally resulted in more extensive delivery of the
chimera to vesicular structures containing GRA3 (Fig. 6 B,
BAP-GY501A) when compared with BAP-G.
Taken together with the data for BAP-GRA4 and mu-
tants, these results suggest that the cytoplasmic tail and
transmembrane domain of an endogenous dense granule
protein is either permissive for or mediates targeting to
dense granules. The cytoplasmic tail from a nondense
granule protein (VSV-G) influences either delivery to or
retention within T. gondii dense granules. Finally, the cy-
toplasmic tail of both an endogenous and a foreign protein
are necessary for efficient secretion into the vacuolar
space.
Subcellular Fractionation of BAP, BAP-GPI, and
BAP-G Confirms Their Microscopic Localization
The behavior of BAP, BAP-GPI, and BAP-G was exam-
ined after subcellular fractionation of infected host cells
(Fig. 7). All reporter proteins were found in large amounts
in the 1,450-g parasite pellet, as expected. Of the material
not sedimenting with parasites, BAP partitioned predomi-
nantly into the 100,000-g supernatant. In contrast, both
BAP-GPI and BAP-G partitioned predominantly into the
10,000-g pellet, containing a portion of the intravacuolar
network and lysed parasite ghosts. Neither was detected in
the 100,000-g supernatant. Thus, all reporters behaved as
expected based on their predicted sequence and micro-
scopic localization.
Discussion
We examined sorting of secreted soluble and membrane
proteins in the pathogenic protozoan parasite Toxoplasma
gondii. While the protein targeting processes within the
parasite could be construed as novel, they are also inter-
pretable as simplified and/or exaggerated versions of sort-
ing mechanisms used by mammalian cells. This is the inter-
pretation we favor, as explained below. In contrast, targeting
of membrane proteins beyond the confines of the organ-
ism and into the surrounding vacuolar space involves un-
usual sorting events.
Two principle models are suggested to account for deliv-
ery of soluble proteins into immature secretory granules
budding from the TGN of higher eukaryotic cells: (a) The
“sorting for entry”/active sorting model invokes binding of
proteins to a secretory granule receptor or acceptor pro-
tein that is concentrated in the TGN and mediates delivery
to the ISG (Rosa et al., 1989; Cool et al., 1997). (b) The
“sorting by retention”/passive sorting model postulates
that preferential aggregation of granule proteins, often in-
duced by low pH and high calcium concentrations (Chanat
and Huttner, 1991; Colomer et al., 1996), occurs within the
ISG, retaining the proteins in the forming granule. In this
model, both “constitutive” and “regulated” proteins enter
ISG, but the former are removed by a vesicular budding
process, generating constitutive secretory vesicles. There
is growing evidence to support this model in both endo-
crine and exocrine cells (Kuliawat and Arvan, 1992, 1994;The Journal of Cell Biology, Volume 141, 1998 1332
Castle et al., 1997). Vesicle budding from ISG is thought to
be a mechanism to remove excess membrane from the
granule during the condensation process leading to forma-
tion of MSG. Since neither we nor others have observed
structures compatible with ISG in T. gondii, and since
budding from ISG is a BFA-sensitive process (De Lisle
and Bansal, 1996; Fernandez et al., 1997), it is possible that
retention of soluble secreted proteins in T. gondii dense
granules reflects the absence of substantial vesicle budding
from these structures during their biogenesis. Our results
are compatible with a simplified view of the passive sort-
ing model for delivery of soluble proteins to dense gran-
ules in T. gondii, in which all soluble proteins are delivered
to dense granules and retained by limiting the options for
removal.
Could sorting of soluble proteins to dense granules be a
consequence of the timing of dense granule gene expres-
sion (e.g., sorting by timing [Cabec et al., 1996])? This is
unlikely for several reasons: (a) Dense granules are
present in T. gondii throughout the cell cycle. (b) Soluble
BAP expressed under the control of the SAG1 promoter
and using the SAG1 signal sequence is still targeted to
dense granules (Karsten, V., and K.A. Joiner, unpublished
observations), as is a fusion of the green fluorescent pro-
tein to the COOH terminus of SAG1 deleted of the GPI
anchor attachment site (Striepen et al., 1998).
Proteins with a GPI anchor are generally transported to
the apical cell surface in polarized epithelial cells (Brown
et al., 1989; for review see Rodriguez-Boulan and Powell,
1992). It has been suggested that GPI-anchored proteins
associate with sphingoglycolipids and form glycolipid rafts
in the TGN (for review see Simons and Eikonen, 1997).
These microdomains are thought to form spontaneously
above a critical concentration of glycolipids and are some-
how configured for apical transport. The most likely expla-
nation for our results is that GPI-anchored proteins in T.
gondii are transported to the plasma membrane in TGN-
derived vesicles, analogous to apical transport vesicles. We
cannot, however, exclude the possibility that GPI-anchored
proteins are transported initially to dense granules and are
subsequently sorted into transport vesicles destined for
the plasma membrane. A recent report suggested that
SAG1 might form detergent-resistant oligomers when GPI
anchored, but to a lesser extent when soluble or when
fused to the transmembrane domain of CD46 (Seeber et al.,
1998). Of interest, the SAG1-CD46 chimera was delivered
to the cell surface, potentially reflecting association of en-
dogenous SAG1 with SAG1-CD46, although transport
vesicles were not identified. In fact, vesicles containing the
GPI-anchored surface proteins of T. gondii have not been
previously identified by either morphologic or biochemi-
cal techniques. Given their size (300–500 nm), the large lu-
cent structures in which both SAG1 and BAP-GPI are lo-
calized in our study are not likely to be CSV. Of interest,
however, is the fact that these structures resemble early
endosomes morphologically (Griffiths et al., 1989). Our
laboratory has recently identified T. gondii rab5 and rab7
homologues (Stedman, T., and K.A. Joiner, unpublished
results), suggesting that structures resembling or function-
ing as early and late endosomes may ultimately be identi-
fied in the parasite.
The mechanism for biogenesis of the intravacuolar net-
work is unclear. If the network is generated by vesiculation
or tubulation from the plasma membrane (Halonen et al.,
1996), sorting of BAP-GPI from BAP-G and BAP-GRA4
must occur at that location. Our results suggest that the cy-
toplasmic tails of membrane proteins could contribute to
the budding process. While the mechanism for such an
event is not clear, it could be analogous to budding of en-
veloped viruses, which is dependent upon binding of cyto-
solic core components of the virus to the cytoplasmic tails
of envelope glycoproteins (e.g., VSV-G [Whitt et al.,
1989]). Alternatively, the network may be released from a
multivesicular structure at a specialized posterior invagi-
nation of the parasite (Sibley et al., 1995), in which case
sorting mediated by the cytoplasmic tail would occur at an
earlier step within the parasite. In either case, there are
few precedents for delivery of transmembrane proteins to
a membranous network outside cells.
Many transmembrane proteins are sorted out of ISG
during maturation to MSG (for review see Urbe et al.,
1997) in a process that typically depends upon sequences
in the cytoplasmic tail. For example, the peptidylglycine
a-amidating monooxygenase is less efficiently retained in
granules as a transmembrane protein than after truncation
of the cytoplasmic tail (Milgram et al., 1994), potentially
analogous to our results with BAP-G. Patches of clathrin
on ISG likely represent sites of coated vesicle formation
directing removal of selected transmembrane proteins,
through interaction with specific motifs in the cytoplasmic
tail that mediate recruitment of the AP-1 adaptor (Dittie
et al., 1997). The ultimate destination for such vesicles is
not known, but could include endosomes, the cell surface,
or vesicles recycling back to the TGN. Clathrin-coated
vesicles are seen adjacent to the trans-most cisternae of
the Golgi in T. gondii (Tilney, L., D. Roos, and M. Shaw,
unpublished observations). While their cargo and destina-
tion is unknown, it is conceivable that they could deliver
BAP-G back to the TGN in a fashion dependent upon the
cytoplasmic tail. In such a model, the GRA4 cytoplasmic
tail would not be recognized by this sorting machinery, ex-
plaining the efficient delivery of BAP-GRA4 to dense
granules.
Figure 7. Subcellular fractionation of infected Vero cells contain-
ing transgenic T. gondii Vero cells infected with T. gondii ex-
pressing either BAP, BAP-GPI, or BAP-G were disrupted by sy-
ringe passage. Intact parasites were pelleted at 1,400 g (1.4K P),
and the supernatant, containing material from the vacuolar space
and from disrupted parasites, was subjected to further differential
centrifugation. Identical parasite equivalents from the 1.4 K P, 10
K P, 100 K P, and 100 K S samples were analyzed by SDS-PAGE
immunoblot with antibodies to BAP. Only BAP is a soluble pro-
tein in the vacuolar space.Karsten et al. Protein Targeting in Toxoplasma gondii 1333
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